Mental health illness is one of the most common disorders globally. Poor accessibility and high cost of conventional face-to-face mental health therapy has created a huge treatment gap. Explore how digital technologies bridge this gap, new innovations, and growth opportunities.
What is the current and predicted future impact of COVID-19 on the growth of this sector? What will be the demand from different site-of-care segments and which segments are poised for better growth? What are the key future innovations? Find out more in this research.
The on-going pandemic has caused a shift in this sector, and this will lead to the rise of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions. Find out more about the changing dynamics and growth drivers in this segment.
Do you have a clearly defined innovation process and know specifically how that ties to your growth pipeline?
Are you satisfied knowing that it is highly likely your team will answer “we are average or below average” to the simple question “Do you have a clearly defined innovation process and know specifically how that ties to your growth pipeline?”
For the last nine months executives from around the world, some of them perhaps reporting to you have answered this way in our Growth Pipeline Diagnostic™. Let me back up for a second and explain where I am coming from. Frost & Sullivan has for 60 years been driving our clients’ growth pipeline and in doing so have identified the best practices for creating a company with the strongest characteristics of innovation and growth. The evidence is stark with 57 of the top 100 companies seeing their revenues decline in the last three years. As a response, our team developed ten insightful questions, each with three best practice benchmarks associated to help our clients deal with the reality of their innovation & growth strategies in place. We were blown away by the responses. This was no normal survey because the way we executed it was different than any other assessment of this kind. Instead of survey blasting out a questionnaire, we chose two methods to compare the way executives respond.
Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Frost Radar— Medical Devices in Atrial Fibrillation Market, 2020
Read more Request InfoFrost Radar—Global Critical Care Patient Monitoring Market, 2020
Read more Request InfoEHR and ICD-10 Transform the EU Computer-assisted Coding Sector
Read more Request InfoStrategic Commercial Partnerships Powering the Biobanking Ecosystem
Read more Request InfoPost-pandemic Outlook of the Global Healthcare Sector Reveals Immense Growth Potential
Read more Request InfoNational eHealth Initiatives Driving Growth in the Global Precision Medicine Segment
Read more Request InfoDisruptive Shifts Driving Growth in the US and EU-5 Custom Procedure Tray Sector
Read more Request InfoGrowth Opportunity Outlook and Key Highlights of the Indian Healthcare Space
Read more Request InfoThe UK MedTech sector is going through a transformational phase. What will be the current and future impact of Covid-19, brexit, life sciences sector deal etc. on UK medtech sector? Which of the growth segments is expected to show high potential for future growth and why? Which are the high potential short and long term growth opportunities to be explored?
Request Info
How is healthcare delivery changing until 2025, and how does that impact the wearables space? Why is patient data becoming a critical piece of care delivery, and how does that promote precision health? What health-tracking features of wearables are gaining importance (after cardiac parameters), and why?
Request Info
What is the strategic imperative of global IVD sector? What is the impact of COVID-19 on global, UAE and KSA IVD industry? Which are the high potential short- and long-term growth opportunities to be explored?
Request Info
Frost & Sullivan’s recent analysis, Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026, finds that aggressive investments in manufacturing technology and capacity are essential to fully harness the curative potential of the cell and gene therapy (CGT) segment. This enables operational efficiency gains and reduces project costs, generating benefits that can be transferred directly to patients.
Frost & Sullivan’s recent analysis, Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024, finds that the outbreak of the COVID-19 pandemic has transformed the infectious disease point-of-care testing (POCT) market. The emergence of cost-effective lab-on-a-chip and smartphone-based POCTs, alongside increasing reliance on less-invasive testing methodologies, will propel the POCT market. Globally, the infectious disease POCT market is estimated to witness more than a three-fold growth, reaching $26.4 billion by 2024 from $7.9 billion in 2019, up at a compound annual growth rate (CAGR) of 27.3%.
Frost & Sullivan’s recent analysis, Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020, finds that rising demand for smart instruments and digital tools within the diagnostics, academic, and commercial research labs will powerfully drive the smart lab market. The thriving market is estimated to nearly double, reaching $4.68 billion by 2023 from $2.39 billion in 2019, registering double-digit growth at a compound annual growth rate (CAGR) of 18.3%.
Read more